Tumor necrosis factor inhibitors continuation rates in patients with psoriatic arthritis: A French retrospective monocentre study

Joint Bone Spine. 2015 Oct;82(5):377-8. doi: 10.1016/j.jbspin.2014.12.012. Epub 2015 Feb 9.

¹ Department of Rheumatology, University Hospital Centre of Caen, avenue de la Côte-de-Nacre, 14033 Caen cedex 9, France. Electronic address: [email protected].
² Department of Immunology, Monash University, Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), 89 Commercial Road, Melbourne, Victoria 3004, Australia.
³ Department of Rheumatology, University Hospital Centre of Caen, avenue de la Côte-de-Nacre, 14033 Caen cedex 9, France.

No abstract available

Keywords: Biologic; Continuation rate; Disease-modifying anti-rheumatic drug (DMARD); Psoriatic arthritis (PsA); Tumour necrosis factor (TNF).

Publication types